Concepedia
Statistics
Publications
11
Citations
861
H-Index
10
Active since
2012
Affiliations
University of Oxford(Current)
University of Nottingham
John Radcliffe Hospital
National Institute for Health and Care Research
MRC Human Immunology Unit
Jennifer Cane is an author at University of Oxford specializing in pharmacotherapy, life sciences, and pathology.
Publications per year
2012–2024
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
Sanjay Ramakrishnan, Dan V. Nicolau, Beverly Langford et al. · The Lancet Respiratory Medicine · 2021 · 434 citations · Full text
Pharmacy, Clinical Sciences, Pharmacotherapy +13
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
Timothy Hinks, Lucy Cureton, Ruth Knight et al. · The Lancet Respiratory Medicine · 2021 · 89 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +8
Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis
William Chang, Jennifer Cane, John Blakey et al. · Respiratory Research · 2012 · 70 citations · Full text
Medicine, Clinical Sciences, Pathology +15
A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis
William Chang, Jennifer Cane, Maruti Kumaran et al. · European Respiratory Journal · 2013 · 64 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +13
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells
Xiaodong Zhuang, Senko Tsukuda, Florian Wrensch et al. · iScience · 2021 · 61 citations · Full text
Life Sciences, Infectious Diseases, Molecular Biology +17
1–5 of 11